Genprex, Inc.
GNPX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6 | $6 | $4 | $9 |
| - Cash | $1 | $1 | $3 | $2 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5 | $5 | $0 | $8 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$5 | -$4 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$5 | -$4 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -5 | -8.5 | -13 | -21 |
| % Growth | 41.2% | 34.6% | 38.1% | – |
| Operating Cash Flow | -$3 | -$4 | -$4 | -$4 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$3 | -$4 | -$4 | -$4 |